High levels of MHCII were also associated with higher CD8, CD4, and CD68 TIL and this was statistically significant for epithelium and stromal areas across tumor groups (i.e. all cases), and in both Luminal A, and Basal-like tumors. Here, CD8A is linked to neoplasm.